Scholarlink

Background <p>Increased risk of post-acute sequelae was found to occur in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 reinfections). However, it is unclear whether these increases in post-acute risk are found in milder Omicron reinfections, or persist in a highly boosted population.</p> Methods <p>We utilised national COVID-19 databases and healthcare-claims records of Singapore to construct SARS-CoV-2 infected and uninfected cohorts over periods of Delta, Omicron BA.1/2, BA.4/5 and XBB predominance (1 July 2021–28 February 2023). The 300-day risk and excess burdens of pre-specified new-incident diagnoses across cardiovascular, neuropsychiatric, endocrine, auto-immune, renal, respiratory and gastrointestinal domains was compared across SARS-CoV-2 re-infected individuals (<i>N</i> = 57,222), SARS-CoV-2-infected individuals without documented re-infection (<i>N</i> = 1,239,119), and population-based un-infected controls (<i>N</i> = 3,409,170). Risk trajectories between groups were compared to examine whether differences in risk of post-acute sequelae persisted over follow-up time.</p> Results <p>There was an estimated 21% (hazards ratios (HR) = 1.21; 95% Confidence interval (CI) [1.15–1.28]) increase in risk of any post-acute sequelae, and increased post-acute risk of cardiovascular (HR = 1.20; 95% CI [1.09–1.32]), gastrointestinal (HR 1.26; 95% CI [1.16–1.38]), neurological (HR 1.32; 95% CI [1.23–1.42]), endocrine (HR 1.26; 95% CI [1.18–1.35]), respiratory (HR 1.63; 95% CI [1.44–1.83]) and renal (HR 1.28; 95% CI [1.12–1.47]) sequelae associated with SARS-CoV-2 reinfections. Associated risks of post-acute sequelae were greater in reinfections compared to first infections. Excess burdens per 1000 of any post-acute sequelae were also higher in reinfected individuals, and reinfected individuals also had higher outcome probabilities of post-acute sequelae over follow-up time. Risks of post-acute sequelae persisted in fully vaccinated and boosted individuals.</p> Conclusions <p>Reinfection with SARS-CoV-2 is associated with increased risk of post-acute sequelae. Reducing burden of post-acute complications due to SARS-CoV-2 necessitates strategies for preventing reinfection, such as updated vaccines with better effectiveness against infection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multi-systemic risk of post-acute sequelae associated with SARS-CoV-2 reinfection

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月19日

查看全文
  • Jue Tao Lim,
  • Liang En Wee,
  • Janice Yu Jin Tan,
  • Luis J. Ponce,
  • Calvin J. Chiew,
  • Benjamin Ong,
  • David Chien Boon Lye,
  • Kelvin Bryan Tan

摘要

Background

Increased risk of post-acute sequelae was found to occur in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 reinfections). However, it is unclear whether these increases in post-acute risk are found in milder Omicron reinfections, or persist in a highly boosted population.

Methods

We utilised national COVID-19 databases and healthcare-claims records of Singapore to construct SARS-CoV-2 infected and uninfected cohorts over periods of Delta, Omicron BA.1/2, BA.4/5 and XBB predominance (1 July 2021–28 February 2023). The 300-day risk and excess burdens of pre-specified new-incident diagnoses across cardiovascular, neuropsychiatric, endocrine, auto-immune, renal, respiratory and gastrointestinal domains was compared across SARS-CoV-2 re-infected individuals (N = 57,222), SARS-CoV-2-infected individuals without documented re-infection (N = 1,239,119), and population-based un-infected controls (N = 3,409,170). Risk trajectories between groups were compared to examine whether differences in risk of post-acute sequelae persisted over follow-up time.

Results

There was an estimated 21% (hazards ratios (HR) = 1.21; 95% Confidence interval (CI) [1.15–1.28]) increase in risk of any post-acute sequelae, and increased post-acute risk of cardiovascular (HR = 1.20; 95% CI [1.09–1.32]), gastrointestinal (HR 1.26; 95% CI [1.16–1.38]), neurological (HR 1.32; 95% CI [1.23–1.42]), endocrine (HR 1.26; 95% CI [1.18–1.35]), respiratory (HR 1.63; 95% CI [1.44–1.83]) and renal (HR 1.28; 95% CI [1.12–1.47]) sequelae associated with SARS-CoV-2 reinfections. Associated risks of post-acute sequelae were greater in reinfections compared to first infections. Excess burdens per 1000 of any post-acute sequelae were also higher in reinfected individuals, and reinfected individuals also had higher outcome probabilities of post-acute sequelae over follow-up time. Risks of post-acute sequelae persisted in fully vaccinated and boosted individuals.

Conclusions

Reinfection with SARS-CoV-2 is associated with increased risk of post-acute sequelae. Reducing burden of post-acute complications due to SARS-CoV-2 necessitates strategies for preventing reinfection, such as updated vaccines with better effectiveness against infection.